The latest piece of economic data suggests that the recovery of the U.S. economy continues to gather steam, even in the stagnant housing market. Permits for home building in February edged near a 3 1/2…
Cardium Therapeutics today announced the initiation of the ASPIRE Phase 3 registration study to evaluate the therapeutic effects of Cardium’s lead product candidate, Generx® (Ad5FGF-4) in patients with myocardial ischemia (insufficient blood flow in the…
NetZero Wireless, Inc., a subsidiary of United Online, yesterday announced the launch of NetZero 4G Mobile Broadband, a fast, affordable, and secure Internet service for netbooks, laptops, iPads, and other tablets. This exciting new service…
GlobalWise Investments and its wholly owned subsidiary Intellinetics, Inc., a leading-edge technology company focused on the design, implementation, and management of cloud-based Enterprise Content Management (“ECM”) systems in both the public and private sectors, today…
SPAR Group Inc., a global supplier of retail merchandising and other marketing services, today announced its 2011 fourth quarter and year-end financial results. For the three months ended December 31, 2011, SPAR reported revenues of…
Today, Recon Technology, which has built a strong reputation within China’s burgeoning oil field services industry as a 10-year veteran, non-state owned, broad spectrum provider of ingenious software and field service equipment engineered to improve…
Today, shortly after the opening bell, FluoroPharma Medical announced that BFPET, its imaging agent for measuring cardiovascular blood flow, has been granted patent rights in Australia. BFPET is a novel cardiovascular blood flow imaging agent…
Today, Avanir Pharmaceuticals announced that the company has appointed Rohan Palekar to the position of senior vice president and chief commercial officer. In his new role, Mr. Palekar will lead all of the company’s commercial…
On Friday, Tucows announced the reinstatement of the stock buyback program that the company had previously put on suspension. The suspension was enacted when Tucow undertook its most recent Dutch Auction Tender, which was completed…
Cross Border Resources reported large year-over-year increases in sales as well as oil and gas production in 2011. The company benefited from increased development of its properties and continuing high prices for crude oil. Cross…
Before you understand the power of social media, it’s important to recognize and respect the sweeping reach of the Internet and its applications. According to U.S. Census Bureau, most recent 2012 numbers estimate that more…
Cytori Therapeutics is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and repair soft tissue defects. The company believes ADRCs improve blood flow, moderate the immune response, and keep…
AdCare Health Systems, a leading long-term care provider, just announced that it has inked definitive purchase agreements for two skilled nursing facilities in Oklahoma for a total consideration of $11.6 million. Adding 239 beds in…
Earlier this month, when TONIX Pharmaceuticals, developer of drugs for treating central nervous system disorders, announced the closing of the final tranche of a private placement financing deal resulting in total net proceeds of $5.9…
TONIX Pharmaceuticals, a New York based company developing treatments for challenging disorders of the central nervous system (CNS), has a unique approach to drug research and development. Instead of going through the time and expense…
Aegis Capital has been in business for 26 years and maintains a conflict-free service platform catering to the needs of private clients, institutions, and corporations. The full service investment banking firm has clients from all…
Lihua International, a Chinese developer, designer, and manufacturer of low-cost, high-quality alternatives to pure copper products, today announced its financial results for the fourth quarter and full year ended December 31, 2011. Lihua reported fourth-quarter…
Currently in Phase 1b clinical development, VistaGen Therapeutics’ lead drug candidate, AV-101, is showing promising potential for the treatment of neuropathic pain and depression. These are huge markets with notable growth prospects, and the unique…
Oncothyreon recently announced that the company had enrolled the first patient for the Phase 1 trial of their ONT-10 vaccine product, intended for cancer patients. The trial is intended to evaluate the safety and immunogenicity…
Yesterday, one of the world’s largest solar companies, Canadian Solar, announced that it has been working with Lightsource Renewable Energy, a leading solar developer, in the completion of four solar power plants throughout England. The…